CJC-1295 / Ipamorelin

CJC-1295/Ipamorelin — Dual Peptide Research Blend Research Use Only | ≥98% Purity

CJC-1295 / Ipamorelin is a dual-compound synthetic research peptide blend combining CJC-1295 and Ipamorelin in a single lyophilized formulation. Both peptides operate within the growth hormone secretagogue pathway and have been extensively studied in preclinical research settings, making their combined formulation of particular interest to researchers investigating growth hormone releasing hormone (GHRH) receptor signaling, ghrelin receptor pharmacology, and pituitary axis regulation in controlled laboratory models.

CJC-1295 (5mg) — A synthetic analog of growth hormone releasing hormone (GHRH), modified with a Drug Affinity Complex (DAC) to extend plasma half-life. Widely researched for its interactions with the GHRH receptor and downstream growth hormone secretion signaling in preclinical models.

Ipamorelin (5mg) — A selective growth hormone secretagogue and ghrelin receptor agonist. Researched for its highly selective stimulation of growth hormone release pathways without significant interaction with cortisol, prolactin, or ACTH secretion pathways, making it a valuable tool for isolated pituitary signaling research.

The combination of these two compounds in a single formulation offers researchers a convenient vehicle for studying synergistic GHRH receptor and ghrelin receptor co-activation within the same research protocol.

All USA Made Peps CJC-1295/Ipamorelin is independently third-party tested to a minimum purity of ≥98% by HPLC and mass spectrometry and supplied with a full Certificate of Analysis.

Available size:

• CJC-1295/Ipamorelin — 5mg/5mg per vial (10 vial pack)
• 5mg/5mg Single Vial

Supplied as lyophilized powder. Store at -20°C. For research use only.

For Research Use Only. Not for human or animal use. Not FDA-approved. Not intended to diagnose, treat, cure, or prevent any disease or condition. For in vitro laboratory research purposes only. Buyer assumes full responsibility for lawful use in their jurisdiction.